Share: Subscribe
DistilNFO M&A
Life Sciences M&A Advisory

Weekly Top News

Mon, 23 Mar 2020

We have 33 articles this week. The week’s biggest highlights are as follows: #Dover to Acquire #Em-tecGmbH, a Leading Designer and Manufacturer of Flow Measurement Devices. European and U.S. Antitrust Authorities Clear Acquisition of Select #DanaherLifeScience Businesses by Sartorius. #Masimo Announces Agreement to Acquire TNI medical #AG.Zymergen Announces Acquisition of #enEvolv, Accelerating Ability to Deliver High-Value Products to Market. #ProtalixBioTherapeutics Announces Closing of $43.7 Million Private Placement. #CirclePharma Raises $45 Million in Series B Financing. #LogistiCare Extend Partnership with #Lyft to Improve Access to Care. Powered by #LyraHealth, #Starbucks Offers U.S. Employees Access to Mental Health Therapist/Coach

Editor’s Choice
1.
COVID-19 Shutdowns in China: Infiniti Research Explains What This Means for the Global Pharmaceutical Supply Chain
2.
Global Pharmacovigilance Market Analysis Report and Forecasts 2020
3.
Biotainer Market Top Companies, Business Insights, Growth,global Market Share, Global Market Size, Trends, Sales, Revenue, Forecast and Detailed Analysis
4.
Vitrectomy Devices Industry Outlook 2019-2024 – Market Insights, Dynamics, Revenue and Forecast
5.
Bioburden Testing Market Research Report 2020 | Industry Report, Industry Analysis, Key Players, Trends, Revenue, Regional Segmented, Outlook Until 2030
Top 10 M&A Transactions
6.
European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius
7.
Masimo Announces Agreement to Acquire TNI medical AG
8.
Zymergen Announces Acquisition of enEvolv, Accelerating Ability to Deliver High-Value Products to Market
9.
Dover to Acquire Em-tec Gmbh, a Leading Designer and Manufacturer of Flow Measurement Devices
10.
AcelRx Buys Tetraphase Pharma for $14.4 Million
11.
Assertio Therapeutics Agrees to Merge with Zyla Life Sciences to Create Synergistic Portfolio of Neurology and Non-Opioid Pain Products
12.
ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
13.
Digipath Completes Acquisition of VSSL Enterprises Ltd.
14.
NewLink Genetics Stockholders Approve Merger with Lumos Pharma
15.
AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
Top 3 Venture Funding
16.
Protalix BioTherapeutics Announces Closing of $43.7 Million Private Placement
17.
Pristine Surgical Completes $18 Million Capital Raise
18.
Circle Pharma Raises $45 Million in Series B Financing
Top 4 Partnerships Announcements
19.
Logisticare Extend Partnership with Lyft to Improve Access to Care
20.
Kyruus, GYANT Integrate to Offer AI-Assisted Provider Search and Self-Scheduling
21.
Powered By Lyra Health, Starbucks Offers U.S. Employees Access to Mental Health Therapist/coach
22.
Alterra.ai and MyMO Launch a Chatbot That can Answer Questions on the Coronavirus Outbreak
Read More Corporate Development and M&A Activity
About Ed Francis
DistilNFO's Executive Editor & Industry Strategist.
Ed has more than 25 years of management consulting experience and currently is the Global Managing Partner for Infosys Consulting Health and Life Sciences business guiding some of the industry's most prominent health and life sciences organizations through complex transformations.

If you need help with your complex transformation whether it be M&A, digital, or strategic cost reduction or need to bring more innovation into your business strategy Ed can be contacted at Edward.Francis@infosys.com and +1-847-910-6073

Or connect with him at

Advertise with us

We Reach Quarter Million Decision Makers in:
Healthcare · IT · Retail · Industrial
Advertise with us and reach the right audience.
advertise@distilnfo.com

Contact Us


5760 Legacy Dr,
ste B3-405,
Plano TX 75024
+1 469-270-3311

About DistilNFO Newsletter

We pick up top 10 news from industries relevent to you and send out the headlines weekly thus saving your time and keeping you up to date on your interest areas.

You are receiving this newsletter because you are subscribed to one or more DistilNFO Publications Newsletter/s. If you feel this email was sent by mistake, you can unsubscribe or update your subscription.

View in browser | Update Subscription | Advertise | Contact Us